Wei Ling Lau, MD

Charlotte Robinson

DocwireNews

AccurKardia recently announced that it received Breakthrough Device Designation from the FDA for its AK+ Guard hyperkalemia detection software. AK+ Guard is also one of just 62 devices accepted into the FDA Total Product Life Cycle Advisory Program. Both FDA initiatives could help hasten the regulatory process and time to commercialization for the new software.
AK+ Guard is artificial intelligence–powered software that uses lead I ECG data to alert patients and clinicians of moderate to severe episodes of hyperkalemia that can lead to sudden cardiac arrest. The software is designed to work with consumer and clinical wearables that capture lead I ECG data, such as smartwatches and Fitbits. This would allow for monitoring hyperkalemia outside the clinic and earlier intervention among at-risk patients, including those with chronic kidney disease or end-stage renal disease and those receiving dialysis or medications for hyperkalemia or any others that could cause hyperkalemia.
Wei Ling Lau, MD, of the University of California, Irvine spoke with Nephrology Times about the potential effect of the new technology on hyperkalemia management.

AK+ Guard for Hyperkalemia Detection

Hyperkalemia

Shubham Pant, MD

Zanidatamab for Biliary Tract Cancer: The HERIZON Trial

Bile Duct Cancer

Laura Litwin

Sublobar Resection Versus Lobectomy for Early-Stage NSCLC: Systematic Review Compares Outcomes

Non-Small Cell Lung Cancer

Latest News

Wei Ling Lau, MD, discussed AccurKardia's AK+ Guard hyperkalemia detection software and its potential impact for people with kidney disease.

AK+ Guard Device for Hyperkalemia Detection

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe